Price Trevor T, Sipkins Dorothy A
Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University, Durham, USA.
Mol Cell Oncol. 2016 Jul 26;4(4):e1214771. doi: 10.1080/23723556.2016.1214771. eCollection 2017.
E-selectin is a key mediator of breast cancer cell (BCC) metastatic entry into the bone and stromal-derived factor 1 (SDF-1) is a critical molecular anchor for BCCs within discrete pro-dormancy bone marrow (BM) niches. Small-molecule inhibitors blocked metastatic entry and mobilized established disease from BM, suggesting a new treatment strategy to prevent breast cancer relapse.
E选择素是乳腺癌细胞(BCC)转移进入骨骼的关键介质,而基质衍生因子1(SDF-1)是离散的前休眠骨髓(BM)龛内BCC的关键分子锚定物。小分子抑制剂可阻断转移进入并从骨髓中动员已形成的疾病,提示了一种预防乳腺癌复发的新治疗策略。